192 related articles for article (PubMed ID: 25436679)
21. Regulation of EMT by TGFβ in cancer.
Heldin CH; Vanlandewijck M; Moustakas A
FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
[TBL] [Abstract][Full Text] [Related]
22. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
24. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
25. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
26. Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway.
Choe C; Shin YS; Kim SH; Jeon MJ; Choi SJ; Lee J; Kim J
Anticancer Res; 2013 Sep; 33(9):3715-23. PubMed ID: 24023301
[TBL] [Abstract][Full Text] [Related]
27. ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.
Vendrell JA; Thollet A; Nguyen NT; Ghayad SE; Vinot S; Bièche I; Grisard E; Josserand V; Coll JL; Roux P; Corbo L; Treilleux I; Rimokh R; Cohen PA
Cancer Res; 2012 Jul; 72(14):3593-606. PubMed ID: 22593193
[TBL] [Abstract][Full Text] [Related]
28. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
29. Induction of epithelial-mesenchymal transition by transforming growth factor β.
Moustakas A; Heldin CH
Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
[TBL] [Abstract][Full Text] [Related]
30. TGFβ and matrix-regulated epithelial to mesenchymal transition.
Moustakas A; Heldin P
Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266
[TBL] [Abstract][Full Text] [Related]
31. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition.
Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845
[TBL] [Abstract][Full Text] [Related]
32. Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β.
Tsubakihara Y; Moustakas A
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463358
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models.
Bandyopadhyay A; Wang L; Agyin J; Tang Y; Lin S; Yeh IT; De K; Sun LZ
PLoS One; 2010 Apr; 5(4):e10365. PubMed ID: 20442777
[TBL] [Abstract][Full Text] [Related]
34. TGFβ Signaling Increases Net Acid Extrusion, Proliferation and Invasion in Panc-1 Pancreatic Cancer Cells: SMAD4 Dependence and Link to Merlin/NF2 Signaling.
Malinda RR; Zeeberg K; Sharku PC; Ludwig MQ; Pedersen LB; Christensen ST; Pedersen SF
Front Oncol; 2020; 10():687. PubMed ID: 32457840
[TBL] [Abstract][Full Text] [Related]
35. TGFβ: A player on multiple fronts in the tumor microenvironment.
Caja F; Vannucci L
J Immunotoxicol; 2015; 12(3):300-7. PubMed ID: 25140864
[TBL] [Abstract][Full Text] [Related]
36. The liver kinase B1 supports mammary epithelial morphogenesis by inhibiting critical factors that mediate epithelial-mesenchymal transition.
Tzavlaki K; Ohata Y; Morén A; Watanabe Y; Eriksson J; Tsuchiya M; Kubo Y; Yamamoto K; Sellin ME; Kato M; Caja L; Heldin CH; Moustakas A
J Cell Physiol; 2023 Apr; 238(4):790-812. PubMed ID: 36791282
[TBL] [Abstract][Full Text] [Related]
37. TGFβ selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition.
Tsubakihara Y; Ohata Y; Okita Y; Younis S; Eriksson J; Sellin ME; Ren J; Ten Dijke P; Miyazono K; Hikita A; Imamura T; Kato M; Heldin CH; Moustakas A
Mol Oncol; 2022 Jun; 16(12):2330-2354. PubMed ID: 35348275
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation.
Dunphy KA; Seo JH; Kim DJ; Roberts AL; Tao L; DiRenzo J; Balboni AL; Crisi GM; Hagen MJ; Chandrasekaran T; Gauger KJ; Schneider SS; Jerry DJ
Cancer Cell Int; 2013; 13():74. PubMed ID: 23883065
[TBL] [Abstract][Full Text] [Related]
39. The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment.
Demirkan B
J Clin Med; 2013 Nov; 2(4):264-82. PubMed ID: 26237148
[TBL] [Abstract][Full Text] [Related]
40. TGFβ signaling networks in ovarian cancer progression and plasticity.
Kumari A; Shonibare Z; Monavarian M; Arend RC; Lee NY; Inman GJ; Mythreye K
Clin Exp Metastasis; 2021 Apr; 38(2):139-161. PubMed ID: 33590419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
